Webinar: A PharmaPendium Case Study - Data driven analyses help identify potential safety risks for a new drug candidate
On Apr 26, 2016 10:00 AM New York
Leveraging precedent information is becoming critically important as pressure is being applied to drive better efficiencies and decrease costs through the entire drug development cycle. This 30 minute case study examines FDA and EMA drug approval information to address drug safety questions using pharmacokinetic and metabolizing enzyme and transporter data found in PharmaPendium. These insights can be proactively applied to the development program for a new drug.